FDA Inspection 1277487 — Vitalant Magee Women's Hospital Site

Vitalant Magee Women's Hospital Site — FEI 3004866289

The FDA completed an inspection of Vitalant Magee Women's Hospital Site on July 30, 2025 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 30, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)